LONDON (Reuters) - U.S. drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.

from Reuters: Top News http://ift.tt/1l1CThd
via IFTTT
from Reuters: Top News http://ift.tt/1l1CThd
via IFTTT
No hay comentarios:
Publicar un comentario